Effects of BRCA1 and BRCA2 mutations on female fertility
- PMID: 21993507
- PMCID: PMC3282366
- DOI: 10.1098/rspb.2011.1697
Effects of BRCA1 and BRCA2 mutations on female fertility
Abstract
Women with BRCA1/2 mutations have a significantly higher lifetime risk of developing breast or ovarian cancer. We suggest that female mutation carriers may have improved fitness owing to enhanced fertility relative to non-carriers. Here we show that women who are carriers of BRCA1/2 mutations living in natural fertility conditions have excess fertility as well as excess post-reproductive mortality in relation to controls. Individuals who tested positive for BRCA1/2 mutations who linked into multi-generational pedigrees within the Utah Population Database were used to identify putative obligate carriers. We find that women born before 1930 who are mutation carriers have significantly more children than controls and have excess post-reproductive mortality risks. They also have shorter birth intervals and end child-bearing later than controls. For contemporary women tested directly for BRCA1/2 mutations, an era when modern contraceptives are available, differences in fertility and mortality persist but are attenuated. Our findings suggest the need to re-examine the wider role played by BRCA1/2 mutations. Elevated fertility of female mutation carriers indicates that they are more fecund despite their elevated post-reproductive mortality risks.
Figures

Comment in
-
BRCA1/2 mutations, fertility and the grandmother effect.Proc Biol Sci. 2012 Aug 7;279(1740):2926-9. doi: 10.1098/rspb.2012.0542. Epub 2012 May 9. Proc Biol Sci. 2012. PMID: 22572204 Free PMC article. No abstract available.
References
-
- Botkin J. R., Croyle R. T., Smith K. R., Baty B. J., Lerman C., Goldgar D. E., Ward J. M., Flick B. J., Nash J. E. 1996. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J. Natl Cancer Inst. 88, 872–88210.1093/jnci/88.13.872 (doi:10.1093/jnci/88.13.872) - DOI - DOI - PubMed
-
- Friedman E., et al. 2006. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 8, R15.10.1186/bcr1387 (doi:10.1186/bcr1387) - DOI - DOI - PMC - PubMed
-
- Mai P. L., Chatterjee N., Hartge P., Tucker M., Brody L., Struewing J. P., Wacholder S., Toland A. E. 2009. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS ONE 4, e4812.10.1371/journal.pone.0004812 (doi:10.1371/journal.pone.0004812) - DOI - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous